| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/11/2010 | CA2732087A1 Substituted naphthyridines and their use as medicaments |
| 02/11/2010 | CA2731897A1 Diazepine and diazocane compounds as mc4 agonists |
| 02/11/2010 | CA2731368A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 02/10/2010 | EP2151442A2 Process for preparing temozolomide |
| 02/10/2010 | EP2150553A1 Condensed heterocyclic compounds as inhibitors of protein kinases |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1699800B1 Bicyclic heterocyclic p-38 kinase inhibitors |
| 02/10/2010 | CN101646674A Indolobenzazepine derivatives for the treatment of hepatitis C |
| 02/10/2010 | CN101646673A 3-amino-pyrrolo[3,4-c] pyrazole- 5 (1h, 4h, 6h) carbaldehyde derivatives as pkc inhibitors |
| 02/10/2010 | CN101646672A Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy |
| 02/10/2010 | CN100588658C Preparing process of 4,7-diazaindole |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/09/2010 | US7659393 Chemical intermediates of gadolinium complexes and cyclene ligand polyfunctinalized with carboxylate arms such as Dotarem, Prohance (gadoteridol) , andGadovist; one pot process of reacting ethyenediamine, glyoxal andbenzotriazole without using dibromo- or dichloroethane |
| 02/09/2010 | US7659301 Controlling photoactivation; reducing oxygen concentration of tissue at site; prevention metabolism; cooling |
| 02/09/2010 | US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 02/09/2010 | CA2557576C Novel benzothiazepine and benzothiepine compounds |
| 02/09/2010 | CA2471265C Pyrimidotriazines as phosphatase inhibitors |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2387503C Fluorescent cobalamins and uses thereof |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/04/2010 | WO2010014930A2 Therapeutic agents |
| 02/04/2010 | WO2010014798A2 Pyrimidotriazinediones and pyrimidopyrimidinediones and methods of using the same |
| 02/04/2010 | WO2010014739A2 Heterocyclic modulators of tgr5 |
| 02/04/2010 | WO2010013925A2 Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof |
| 02/04/2010 | WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor |
| 02/04/2010 | WO2010012781A2 New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative |
| 02/04/2010 | WO2009099596A4 Macrocyclic serine protease inhibitors |
| 02/04/2010 | US20100029934 Process for production of mirtazapine |
| 02/04/2010 | US20100029731 Method for preparing largazole analogs and uses thereof |
| 02/04/2010 | US20100029703 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 02/04/2010 | US20100029657 Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof |
| 02/04/2010 | US20100029656 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/04/2010 | US20100029655 Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them |
| 02/04/2010 | US20100029638 Fused heterocyclyc inhibitor compounds |
| 02/04/2010 | US20100029636 Lck inhibitors |
| 02/04/2010 | US20100029630 Reverse-turn mimetics and method relating thereto |
| 02/04/2010 | US20100029622 Microemulsions |
| 02/04/2010 | US20100029619 Fused heterocyclic compound |
| 02/04/2010 | US20100029617 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 02/04/2010 | US20100029616 Urotensin ii receptor antagonists |
| 02/04/2010 | US20100029041 Organic semiconductor material and organic electronic device |
| 02/04/2010 | US20100029010 Diaminorhodamine Derivative |
| 02/04/2010 | DE102008035209A1 New nitrogen substituted heterocyclic compounds are glycogen synthase kinase 3-beta inhibitors useful e.g. to treat and/or prevent hematological disease, preferably leukopenia, and for ex-vivo increase of adult hematopoietic stem cells |
| 02/04/2010 | CA2732628A1 Therapeutic agents |
| 02/04/2010 | CA2729045A1 Pyrimidine compounds, compositions and methods of use |
| 02/03/2010 | EP2149575A1 Diazabicyclic compounds as opioid receptor agonists |
| 02/03/2010 | EP2149370A1 Diazabicyclic compounds and microemulsions thereof |
| 02/03/2010 | EP2148881A1 Fluorinated lanthanide probes for 19f magnetic resonance applications |
| 02/03/2010 | EP2148880A1 P70 s6 kinase inhibitors |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | EP1421938B1 Antitumor agents and process for producing the same |
| 02/03/2010 | CN101641359A Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/03/2010 | CN101638411A Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 02/02/2010 | US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/02/2010 | US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655686 2-(6-oxo-1,7-diaza-spiro[4.4]non-7-yl)-propionamides such as 4-(S)-hydroxy-5-(S)-[2-(S)-(1-isobutyl-6-oxo-1,7-diaza-spiro(S)-[4.4]non-7-yl)-propionylamino]-2-(R)-methyl-6-phenyl-hexanoic acid butylamide; inhibitors of aspartic proteases such as beta-secretase |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655665 Nitromethylene derivatives and their use |
| 02/02/2010 | US7655654 Tetrazole substituted quinazoline compounds for antiproliferation agents |
| 02/02/2010 | US7655651 Biphenyl-4-carboxylic acid (4-chloro-3-{7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide; protein kinase inhibitors |
| 02/02/2010 | US7655650 Oxadiazine derivatives |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655643 (8S,11S,14S)-14-Amino-11-(3-aminopropyl)-5-fluoro -17-hydroxy-10,13-dioxo-9,12-diazatricyclo[14.3.1.12,6]henicosa-1(20),2(21),3,5,16,18-hexaene-8-carboxylic acid dihydrochloride; antibacterial activity on S. aureus strains which are resistant to biphenomycin |
| 02/02/2010 | US7655642 3-cyano-quinoline derivatives with antiproliferative activity |
| 02/02/2010 | US7655323 That can stabily emit light with various spectra, including high energy blue spectra; tris(1-(2'-(9',9'-dimethyl)fluorenyl)-3-methyl-imidazolin-2-ylidene-C,C3') iridium(III); organic light emitting devices |
| 02/02/2010 | CA2529245C Process to form compound with indolocarbazole moieties |
| 02/02/2010 | CA2345838C Method for the synthesis of radiolabeled compounds |
| 01/31/2010 | CA2674011A1 Pharmaceutical compounds |
| 01/31/2010 | CA2674006A1 Microemulsions |
| 01/28/2010 | WO2010011837A1 Fused heterocyclic compounds useful as kinase modulators |
| 01/28/2010 | WO2010011658A2 Pyromellitic diimide organic semiconductors and devices |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011620A1 4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/28/2010 | WO2010010347A1 Pyrrolobenzodiazepines |
| 01/28/2010 | WO2009120094A3 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022771 Reaction apparatus, and reaction method |
| 01/28/2010 | US20100022768 Reactive 1,3'-crosslinked carbocyanines and their bioconjugates |
| 01/28/2010 | US20100022609 Novel crystalline forms of temozolomide |
| 01/28/2010 | US20100022564 Purine and deazapurine derivatives as pharmaceutical compounds |
| 01/28/2010 | US20100022560 Thiophene pyrazolopyrimidine compounds |
| 01/28/2010 | US20100022548 Use of n-heterocyclylmethylbenzamides in therapeutics |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022508 Antiviral compounds |
| 01/28/2010 | US20100022506 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/28/2010 | US20100022503 tyrosine kinase inhibitors such as Ethyl 3-(3-(pyrrolo[1,2-f][1,2,4]triazin-4-ylamino)-1H-pyrazol-5-ylthio)benzoate, useful as anticarcinogenic or antiproliferative agents |
| 01/28/2010 | US20100022490 Zilpaterol Enantiomer Compositions and Methods of Making and Using Such Compositions |
| 01/28/2010 | US20100021425 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 01/28/2010 | US20100019670 Organic electroluminescent device and platinum compound |
| 01/28/2010 | CA2728932A1 Pyrrolobenzodiazepines |
| 01/27/2010 | EP2147914A1 Aminodihydrothiazine derivatives substituted with cyclic groups |
| 01/27/2010 | EP2146996A1 Xanthine compounds having a positive allosteric gabab receptor modulator effect |
| 01/27/2010 | EP2146995A1 Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy |
| 01/27/2010 | EP1656353B1 Gabanergic modulators |
| 01/27/2010 | CN101633658A Crystalline polymorph of sitagliptin phosphate and its preparation |
| 01/27/2010 | CN100584844C Imidazo 1,2-c pyrimidinylacetic acid derivatives |
| 01/27/2010 | CN100584830C Gabanergic modulators |